Nicotinamide Adenine Dinucleotide Market Share, Size, Trends, Industry Analysis Report, By Grade (Food Grade, Pharmaceutical Grade, and Others); By Application; By Region; Segment Forecast, 2023- 2032

Nicotinamide Adenine Dinucleotide Market Share, Size, Trends, Industry Analysis Report, By Grade (Food Grade, Pharmaceutical Grade, and Others); By Application; By Region; Segment Forecast, 2023- 2032

The global nicotinamide adenine dinucleotide market size is expected treach USD 1,722.11 million by 2032, according ta new study by Polaris Market Research. The report “Nicotinamide Adenine Dinucleotide Market Share, Size, Trends, Industry Analysis Report, By Grade (Food Grade, Pharmaceutical Grade, and Others); By Application; By Region; Segment Forecast, 2023-2032” gives a detailed insight intcurrent market dynamics and provides analysis on future market growth.

Increasing product penetration as a key supplement for a variety of food ingredients because of the NAD’s antioxidant properties coupled with the surge in consumer awareness regarding the health benefits of the product and continuously growing healthcare spending capacity of people across both developed and developing countries are key factors expected tboost the market growth. Moreover, the increasing focus of major market players on developing more advanced and innovative solutions ttackle various issues associated with human health through heavily investing in R&D activities is alscreating huge growth opportunities in the market.

NAD+ has been studied extensively across the globe over the last few decades and continues treceive current research attention as several new roles and functions of this cofactor have significantly emerged in the regulation of protein modifications that could help regulate cellular metabolism and a wide range of cellular events. Recent studies have alsshown that NAD+ levels can profoundly eliminate or reduce cell damage in catabolic tissue, including the brain. Therefore, the promotion of intracellular NAD+ anabolism shows promising market growth.

Moreover, the NAD+ concentration increases under various conditions associated with reduced energy loads, including glucose deprivation, fasting, caloric restriction, and exercise. Apart from this, these levels are highly elevated under conditions of increased life span or health span, representing a major contributor taging. Thus, supplementation with the product and its precursors might define a potential therapeutic strategy tmediate protection against the accumulation of inflammation and highly volatile ROS during aging.

Nicotinamide Adenine Dinucleotide Market Report Highlights

Food grade segment accounted for over considerable global market share in 2022, which is mainly accelerated by its growing adoption as a substrate across various biological processes including DNA repair

Dietary supplements segment dominated the global market in 2022, on account of the widespread adoption of product as an alternative for vitamins and having the ability thelp in living longer and healthier lives

Asia Pacific region is expected twitness highest growth rate throughout the forecast period, owing tincreasing consumer proliferation for improving immunization and high product adoption across the pharma sector

The global key market players include Jubilant Life Sciences, TCI Chemicals, Vertellus Holdings, Zhenjiang LanbBiotechnology, Himedia Laboratories, and Catalent.

Polaris Market Research has segmented the nicotinamide adenine dinucleotide market report based on grade, application, and region:

Nicotinamide Adenine Dinucleotide, Grade Outlook (Revenue - USD Million, 2019 - 2032)

Food Grade

Pharmaceutical Grade

Others

Nicotinamide Adenine Dinucleotide, Application Outlook (Revenue - USD Million, 2019 - 2032)

Dietary Supplements

Pharmaceuticals

Anti-aging Products

Others

Nicotinamide Adenine Dinucleotide, Regional Outlook (Revenue - USD Million, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa